comparemela.com

Nasus Pharma Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nasus Pharma Announces Positive Clinical Results of Recent Phase 2 Study With FMXIN002 Intranasal Epinephrine

Rapid and higher epinephrine absorption- for potentially quicker rescue of patients in anaphylactic shock

United statesUdi gilboaYoseph caracoDalia megiddoNasus pharmaPrnewswire nasus pharma ltdNasus pharma ltdPharma ltdClinical immunologyExecutive chairmanPowder based epinephrineUnidose powderIntranasal naloxoneIntranasal epinephrine

Nasus Pharma Announces Publication of Positive Clinical Results with Epinephrine Intranase Powder Aerosol

(Information sent by the signatory company)

United statesTel avivDalia meguidoNassus pharmaNasus pharmaNasus pharma ltdClinical immunology unit at hadassah medical centerYuval talClinical immunology unitHadassah medical centerUnidose powder devicePharma ltd

Transmucosal Drug Delivery Pipeline Research Report 2023: Formulate Effective R&D Strategies with Key Insights

/PRNewswire/ The "Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key.

United statesIsrael generalNew south walesLaura woodHarm reduction therapeutics incHebrew university of jerusalemProducts under developmentBespak europe ltdInternational partnershipUniversity of the witwatersrandLyra therapeutics incKytogenics pharmaceuticals incGrunenthal ltdFerring pharmaceuticalsRenown pharmaceuticals pvt ltdAtossa therapeutics inc

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

/PRNewswire/ Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address.

United statesBarbaraj mannElla mendelsonH hypromellose taffixNasus pharmaMicha gladnikoffPrnewswire nasus pharmaMegiddo daliaG brett moreauYaron droriKlang shmuelDalia megiddoMichal mandelboimNaparstek yaakovUdi gilboaNasus pharma ltd

Nasus Pharma Announces Clinical Data Demonstrating Efficacy of Taffix®, Intranasal Antiviral Protection Against Common Cold and Upper Respiratory Infection

/PRNewswire/ Nasus Pharma a privately held clinical-stage biopharmaceutical company developing a powder-based intranasal (PBI) product portfolio to address.

United statesBarbaraj mannElla mendelsonH hypromellose taffixNasus pharmaMicha gladnikoffPrnewswire nasus pharmaMegiddo daliaG brett moreauYaron droriKlang shmuelDalia megiddoMichal mandelboimNaparstek yaakovUdi gilboaNasus pharma ltd

vimarsana © 2020. All Rights Reserved.